ARTICLE | Distillery Therapeutics
Therapeutics: Enhancer of zeste homolog 2 (EZH2)
December 17, 2015 8:00 AM UTC
Cell culture and mouse studies suggest inhibiting EZH2 phosphorylation could help treat drug-resistant MM. In a human cell-based model of doxorubicin-resistant MM, knockdown of kinases that phosphoryl...